TY - JOUR
T1 - Corrigendum to: National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025" [Heart Lung Circ. 34(4) (2025) 309-397.]
AU - other members of the Heart Foundation Working Group
AU - Brieger, David
AU - Cullen, Louise
AU - Briffa, Tom
AU - Zaman, Sarah
AU - Scott, Ian
AU - Papendick, Cynthia
AU - Bardsley, Kimberley
AU - Baumann, Angus
AU - Bennett, Alexandra Sasha
AU - Clark, Robyn A
AU - Edelman, J James
AU - Inglis, Sally C
AU - Kuhn, Lisa
AU - Livori, Adam
AU - Redfern, Julie
AU - Schneider, Hans
AU - Stewart, Jeanine
AU - Thomas, Liza
AU - Wing-Lun, Edwina
AU - Zhang, Ling
AU - Ho, Elaine
AU - Matthews, Stacey
N1 - Publisher Copyright:
© 2025 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)
PY - 2026/1
Y1 - 2026/1
N2 - Corrected:
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
David Brieger, Louise Cullen, Tom Briffa ...
March 31, 2025
The authors provide the following changes to the original publication:
i. To clarify to whom the STEMI (ST-segment elevation myocardial infarction) recommendations apply, in the ‘Summary of Recommendations’ Table (‘Acute management of STEMI’ p314) a hashtag is added and the footnotes updated.
“#These recommendations apply to people with ECG changes that may not be recognised as STEMI but are indicative of ACOMI, specifically: high lateral myocardial infarction (MI), posterior MI, right ventricular MI, De Winter T waves, left bundle branch block with modified Sgarbossa criteria.
∗Use of the word lifestyle here refers to a collective group of modifiable risk factors. The authors wish to acknowledge that these risk factors are not solely dependent on individual choice, and instead reflect the cultural, social and environmental factors that influence behaviour. This term does not in any way attribute blame to individuals.”
ii. In the ‘Intended Audience’ section (p320), the first paragraph is changed to include paramedics.
“Intended Audience
This guideline is intended for use by all healthcare professionals involved in the care of people with ACS. These include cardiologists, emergency physicians, paramedics, general practitioners, nurses and nurse practitioners, First Nations health workers and practitioners, pharmacists and other allied healthcare professionals.”
iii. Given that prasugrel is now available in Australia, the Figure 15 footnote and abbreviations (p372) are updated.
The authors apologise for any inconvenience caused.
AB - Corrected:
National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025
David Brieger, Louise Cullen, Tom Briffa ...
March 31, 2025
The authors provide the following changes to the original publication:
i. To clarify to whom the STEMI (ST-segment elevation myocardial infarction) recommendations apply, in the ‘Summary of Recommendations’ Table (‘Acute management of STEMI’ p314) a hashtag is added and the footnotes updated.
“#These recommendations apply to people with ECG changes that may not be recognised as STEMI but are indicative of ACOMI, specifically: high lateral myocardial infarction (MI), posterior MI, right ventricular MI, De Winter T waves, left bundle branch block with modified Sgarbossa criteria.
∗Use of the word lifestyle here refers to a collective group of modifiable risk factors. The authors wish to acknowledge that these risk factors are not solely dependent on individual choice, and instead reflect the cultural, social and environmental factors that influence behaviour. This term does not in any way attribute blame to individuals.”
ii. In the ‘Intended Audience’ section (p320), the first paragraph is changed to include paramedics.
“Intended Audience
This guideline is intended for use by all healthcare professionals involved in the care of people with ACS. These include cardiologists, emergency physicians, paramedics, general practitioners, nurses and nurse practitioners, First Nations health workers and practitioners, pharmacists and other allied healthcare professionals.”
iii. Given that prasugrel is now available in Australia, the Figure 15 footnote and abbreviations (p372) are updated.
The authors apologise for any inconvenience caused.
UR - https://www.scopus.com/pages/publications/105027140634
U2 - 10.1016/j.hlc.2025.12.009
DO - 10.1016/j.hlc.2025.12.009
M3 - Comment/debate/opinion
C2 - 41506818
SN - 1444-2892
VL - 35
SP - e12-e13
JO - Heart, Lung and Circulation
JF - Heart, Lung and Circulation
IS - 1
ER -